Structural Modifications in Polymeric Micelles to Impart Multifunctionality for Improved Drug Delivery

References

• Nicolas J Mura S Brambilla D Mackiewicz N Couvreur P . Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. Chem. Soc. Rev.42 (3), 1147–1235 (2013).
   PubMed Web of Science ®Google Scholar
• Chen YC Lo CL Hsiue GH . Multifunctional nanomicellar systems for delivering anticancer drugs. J. Biomed. Mater. Res. A.102 (6), 2024–2038 (2014).
   PubMed Web of Science ®Google Scholar
• Bader H Ringsdorf H Schmid B . Watersoluble polymers in medicine. Macromol. Mater. Eng.123 (1), 457–485 (1984).
   Google Scholar
• Yuan ZQ Li JZ Liu Y et al. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer. Int. J. Pharm.492 (1–2), 141–151 (2015).
   PubMedGoogle Scholar
• Mittal A Chitkara D Behrman SW Mahato RI . Efficacy of gemcitabine conjugated and miR-205 cmplexed micelles for treatment of advanced pancreatic cancer. Biomaterials35 (25), 7077–7087 (2014).
   PubMed Web of Science ®Google Scholar
• Andrade F Neves JD Gener P et al. Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin. Nanomedicine11 (7), 1621–1631 (2015).
   PubMed Web of Science ®Google Scholar
• Matsumura Y Maeda H . A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res.46 (12 Pt 1), 6387–6392 (1986).
   PubMed Web of Science ®Google Scholar
• Maeda H Wu J Sawa T Matsumura Y Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release65 (1–2), 271–284 (2000).
   PubMed Web of Science ®Google Scholar
• Sun Y Li Y Nan S Zhang L Huang H Wang J . Synthesis and characterization of pH-sensitive poly(itaconic acid)-poly(ethylene glycol)-folate-poly(l-histidine) micelles for enhancing tumor therapy and tunable drug release. J. Colloid Interface Sci.458, 119–129 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang J Zhang M Ji J et al. Glycyrrhetinic acid-mediated polymeric drug delivery targeting the acidic microenvironment of hepatocellular carcinoma. Pharm. Res.32 (10), 3376–3390 (2015).
   PubMed Web of Science ®Google Scholar
• Wang X Yang Y Jia H et al. Peptide decoration of nanovehicles to achieve active targeting and pathology-responsive cellular uptake for bone metastasis chemotherapy. Biomater. Sci.2 (7), 961–971 (2014).
   PubMed Web of Science ®Google Scholar
• Sutton D Nasongkla N Blanco E Gao J . Functionalized micellar systems for cancer targeted drug delivery. Pharm. Res.24 (6), 1029–1046 (2007).
   PubMed Web of Science ®Google Scholar
• Benahmed A Ranger M Leroux JC . Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide). Pharm. Res.18 (3), 323–328 (2001).
   PubMed Web of Science ®Google Scholar
• Torchilin VP Levchenko TS Whiteman KR et al. Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials22 (22), 3035–3044 (2001).
   PubMed Web of Science ®Google Scholar
• Wang F Du J . Disclosing the nature of thermo-responsiveness of poly(N-isopropyl acrylamide)-based polymeric micelles: aggregation or fusion?Chem. Commun. (Camb).51 (56), 11198–11201 (2015).
   PubMed Web of Science ®Google Scholar
• Wu Y Lai Q Lai S Wu J Wang W Yuan Z . Facile fabrication of core cross-linked micelles by RAFT polymerization and enzyme-mediated reaction. Colloids Surf. B Biointerfaces118, 298–305 (2014).
   PubMed Web of Science ®Google Scholar
• Gao X Wang S Wang B et al. Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations. Biomaterials53, 646–658 (2015).
   PubMed Web of Science ®Google Scholar
• Rizis G van de Ven TG Eisenberg A . Homopolymers as structure-driving agents in semicrystalline block copolymer micelles. ACS Nano9 (4), 3627–3640 (2015).
   PubMed Web of Science ®Google Scholar
• Hu Y Darcos V Monge S Li S . Thermo-responsive drug release from self-assembled micelles of brush-like PLA/PEG analogues block copolymers. Int. J. Pharm.491 (1–2), 152–161 (2015).
   PubMed Web of Science ®Google Scholar
• Cong Y Quan C Liu M et al. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin. J. Biomater. Sci. Polym. Ed.26 (11), 629–643 (2015).
   PubMed Web of Science ®Google Scholar
• Waton G Michels B Zana R . Dynamics of micelles of polyethyleneoxide-polypropyleneoxide-polyethyleneoxide block copolymers in aqueous solutions. J. Colloid Interface Sci.212 (2), 593–596 (1999).
   PubMed Web of Science ®Google Scholar
• Quader S Cabral H Mochida Y et al. Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy. J. Control. Release188, 67–77 (2014).
   PubMed Web of Science ®Google Scholar
• Nita LE Chiriac AP Bercea M . Effect of pH and temperature upon self-assembling process between poly(aspartic acid) and Pluronic F127. Colloids Surf. B Biointerfaces119, 47–54 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang X Chen D Ba S et al. Poly(l-histidine) based triblock copolymers: pH induced reassembly of copolymer micelles and mechanism underlying endolysosomal escape for intracellular delivery. Biomacromolecules15 (11), 4032–4045 (2014).
   PubMed Web of Science ®Google Scholar
• Lin YX Gao YJ Wang Y et al. pH-Sensitive polymeric nanoparticles with Gold(I) compound payloads synergistically induce cancer cell death through modulation of autophagy. Mol. Pharm.12 (8), 2869–2878 (2015).
   PubMedGoogle Scholar
• Saadat E Amini M Khoshayand MR Dinarvand R Dorkoosh FA . Synthesis and optimization of a novel polymeric micelle based on hyaluronic acid and phospholipids for delivery of paclitaxel, in vitro and in-vivo evaluation. Int. J. Pharm.475 (1–2), 163–173 (2014).
   PubMedGoogle Scholar
• Gao H Liu J Yang C et al. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles. Int. J. Nanomedicine8, 4229–4246 (2013).
   PubMed Web of Science ®Google Scholar
• Jelonek K Li S Wu X Kasperczyk J Marcinkowski A . Self-assembled filomicelles prepared from polylactide/poly(ethylene glycol) block copolymers for anticancer drug delivery. Int. J. Pharm.485 (1–2), 357–364 (2015).
   PubMedGoogle Scholar
• Gao Y Zhou Y Zhao L et al. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles. Acta Biomater.23, 127–135 (2015).
   PubMed Web of Science ®Google Scholar
• Yue J Liu S Mo G Wang R Jing X . Active targeting and fluorescence-labeled micelles: preparation, characterization and cellular uptake evaluation. J. Control. Release.152 (Suppl. 1), e258–e260 (2011).
   PubMedGoogle Scholar
• Torchilin V . Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur. J. Pharm. Biopharm.71 (3), 431–444 (2009).
   PubMed Web of Science ®Google Scholar
• Maeda H . Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug. Chem.21 (5), 797–802 (2010).
   PubMed Web of Science ®Google Scholar
• Jain RK Stylianopoulos T . Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol.7 (11), 653–664 (2010).
   PubMed Web of Science ®Google Scholar
• Fang J Nakamura H Maeda H . The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev.63 (3), 136–151 (2011).
   PubMed Web of Science ®Google Scholar
• Mima Y Hashimoto Y Shimizu T Kiwada H Ishida T . Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein. Mol. Pharm.12 (7), 2429–2435 (2015).
   PubMedGoogle Scholar
• Abu Lila AS Kiwada H Ishida T . The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. J. Control. Release172 (1), 38–47 (2013).
   PubMed Web of Science ®Google Scholar
• Shiraishi K Yokoyama M . Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenon. Biol. Pharm. Bull.36 (6), 878–882 (2013).
   PubMed Web of Science ®Google Scholar
• Park K . Mechanistic study on the ABC phenomenon of PEG conjugates. J. Control. Release165 (3), 234 (2013).
   PubMed Web of Science ®Google Scholar
• Lin WJ Kao LT . Cytotoxic enhancement of hexapeptide-conjugated micelles in EGFR high-expressed cancer cells. Expert Opin. Drug Deliv.11 (10), 1537–1550 (2014).
   PubMed Web of Science ®Google Scholar
• Danhier F Feron O Preat V . To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release148 (2), 135–146 (2010).
   PubMed Web of Science ®Google Scholar
• Talelli M Oliveira S Rijcken CJ et al. Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy. Biomaterials34 (4), 1255–1260 (2013).
   PubMed Web of Science ®Google Scholar
• Yang G Wang J Wang Y Li L Guo X Zhou S . An implantable active-targeting micelle-in-nanofiber device for efficient and safe cancer therapy. ACS Nano9 (2), 1161–1174 (2015).
   PubMed Web of Science ®Google Scholar
• Mei D Lin Z Fu J et al. The use of alpha-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to alpha7 nAChR-overexpressing breast cancer. Biomaterials42, 52–65 (2015).
   PubMed Web of Science ®Google Scholar
• Durymanov MO Rosenkranz AA Sobolev AS . Current approaches for improving intratumoral accumulation and distribution of nanomedicines. Theranostics5 (9), 1007–1020 (2015).
   PubMed Web of Science ®Google Scholar
• Wang Y Wang H Chen Y Liu X Jin Q Ji J . pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules. Colloids Surf. B Biointerfaces.121, 189–195 (2014).
   PubMed Web of Science ®Google Scholar
• Yen HC Cabral H Mi P et al. Light-induced cytosolic activation of reduction-sensitive camptothecin-loaded polymeric micelles for spatiotemporally controlled in vivo chemotherapy. ACS Nano8 (11), 11591–11602 (2014).
   PubMed Web of Science ®Google Scholar
• Butt AM Mohd Amin MC Katas H . Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs. Int. J. Nanomedicine10, 1321–1334 (2015).
   PubMed Web of Science ®Google Scholar
• Porsch C Zhang Y Montanez MI et al. Disulfide-functionalized unimolecular micelles as selective redox-responsive nanocarriers. Biomacromolecules16 (9), 2872–2883 (2015).
   PubMed Web of Science ®Google Scholar
• Chiang YT Yen YW Lo CL . Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer. Biomaterials61, 150–161 (2015).
   PubMed Web of Science ®Google Scholar
• Rolland A O'Mullane J Goddard P Brookman L Petrak K . New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene‐‐b-oxyethylene) block copolymer aggregates. J. Appl. Polym. Sci.44 (7), 1195–1203 (1992).
   Web of Science ®Google Scholar
• Talelli M Barz M Rijcken CJ Kiessling F Hennink WE Lammers T . Core-crosslinked polymeric micelles: principles, preparation, biomedical applications and clinical translation. Nano Today10 (1), 93–117 (2015).
   PubMed Web of Science ®Google Scholar
• Fan W Wang Y Dai X Shi L Mckinley D Tan C . Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery. Pharm. Res.32 (4), 1325–1340 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang A Zhang Z Shi F et al. Redox-sensitive shell-crosslinked polypeptide-block-polysaccharide micelles for efficient intracellular anticancer drug delivery. Macromol. Biosci.13 (9), 1249–1258 (2013).
   PubMed Web of Science ®Google Scholar
• Zhao Z Yao X Zhang Z Chen L He C Chen X . Boronic acid shell-crosslinked dextran-b-PLA micelles for acid-responsive drug delivery. Macromol. Biosci.14 (11), 1609–1618 (2014).
   PubMed Web of Science ®Google Scholar
• Li S He Q Chen T et al. Controlled co-delivery nanocarriers based on mixed micelles formed from cyclodextrin-conjugated and cross-linked copolymers. Colloids Surf. B Biointerfaces.123, 486–492 (2014).
   PubMed Web of Science ®Google Scholar
• Gratton SE Ropp PA Pohlhaus PD et al. The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA105 (33), 11613–11618 (2008).
   PubMed Web of Science ®Google Scholar
• Jiang C Wang H Zhang X et al. Deoxycholic acid-modified chitooligosaccharide/mPEG-PDLLA mixed micelles loaded with paclitaxel for enhanced antitumor efficacy. Int. J. Pharm.475 (1–2), 60–68 (2014).
   PubMedGoogle Scholar
• Jeong JH Kim SH Kim SW Park TG . Intracellular delivery of poly(ethylene glycol) conjugated antisense oligonucleotide using cationic lipids by formation of self-assembled polyelectrolyte complex micelles. J. Nanosci. Nanotechnol.6 (9–10), 2790–2795 (2006).
   PubMed Web of Science ®Google Scholar
• Lee Y Miyata K Oba M et al. Charge-conversion ternary polyplex with endosome disruption moiety: a technique for efficient and safe gene delivery. Angew. Chem. Int. Ed Engl.47 (28), 5163–5166 (2008).
   PubMed Web of Science ®Google Scholar
• Han SS Li ZY Zhu JY et al. Dual-pH sensitive charge-reversal polypeptide micelles for tumor-triggered targeting uptake and nuclear drug delivery. Small11 (21), 2543–2554 (2015).
   PubMed Web of Science ®Google Scholar
• Arote R Kim TH Kim YK et al. A biodegradable poly(ester amine) based on polycaprolactone and polyethylenimine as a gene carrier. Biomaterials28 (4), 735–744 (2007).
   PubMed Web of Science ®Google Scholar
• Deng H Liu J Zhao X et al. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. Biomacromolecules15 (11), 4281–4292 (2014).
   PubMed Web of Science ®Google Scholar
• Kim HJ Ishii A Miyata K et al. Introduction of stearoyl moieties into a biocompatible cationic polyaspartamide derivative, PAsp(DET), with endosomal escaping function for enhanced siRNA-mediated gene knockdown. J. Control. Release145 (2), 141–148 (2010).
   PubMed Web of Science ®Google Scholar
• Oba M Miyata K Osada K et al. Polyplex micelles prepared from omega-cholesteryl PEG-polycation block copolymers for systemic gene delivery. Biomaterials32 (2), 652–663 (2011).
   PubMed Web of Science ®Google Scholar
• Burnett JC Rossi JJ . RNA-based therapeutics: current progress and future prospects. Chem. Biol.19 (1), 60–71 (2012).
   PubMed Web of Science ®Google Scholar
• Kim HJ Ishii T Zheng M et al. Multifunctional polyion complex micelle featuring enhanced stability, targetability, and endosome escapability for systemic siRNA delivery to subcutaneous model of lung cancer. Drug Deliv. Transl. Res.4 (1), 50–60 (2014).
   PubMed Web of Science ®Google Scholar
• Liu J Deng H Liu Q et al. Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo. Nanoscale7 (10), 4451–4460 (2015).
   PubMed Web of Science ®Google Scholar
• Wang CH Hsiue GH . New amphiphilic poly(2-ethyl-2-oxazoline)/poly(L-lactide) triblock copolymers. Biomacromolecules4 (6), 1487–1490 (2003).
   PubMed Web of Science ®Google Scholar
• Zhao Y Zhou Y Wang D et al. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Acta Biomater.17, 182–192 (2015).
   PubMed Web of Science ®Google Scholar
• Vihinen P Ala-aho R Kahari VM . Matrix metalloproteinases as therapeutic targets in cancer. Curr. Cancer Drug Targets5 (3), 203–220 (2005).
   PubMed Web of Science ®Google Scholar
• Chen WH Luo GF Lei Q et al. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chem. Commun. (Camb.)51 (3), 465–468 (2015).
   PubMed Web of Science ®Google Scholar
• Kang Y Ha W Liu YQ et al. pH-responsive polymer-drug conjugates as multifunctional micelles for cancer-drug delivery. Nanotechnology25 (33), 335101 (2014).
   PubMed Web of Science ®Google Scholar
• Rijcken CJ Snel CJ Schiffelers RM van Nostrum CF Hennink WE . Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials28 (36), 5581–5593 (2007).
   PubMed Web of Science ®Google Scholar
• Talelli M Iman M Varkouhi AK et al. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. Biomaterials31 (30), 7797–7804 (2010).
   PubMed Web of Science ®Google Scholar
• Werner ME Cummings ND Sethi M et al. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys.86 (3), 463–468 (2013).
   PubMed Web of Science ®Google Scholar
• Gindy ME Panagiotopoulos AZ Prud'homme RK . Composite block copolymer stabilized nanoparticles: simultaneous encapsulation of organic actives and inorganic nanostructures. Langmuir24 (1), 83–90 (2008).
   PubMed Web of Science ®Google Scholar
• Duong AD Ruan G Mahajan K Winter JO Wyslouzil BE . Scalable, semicontinuous production of micelles encapsulating nanoparticles via electrospray. Langmuir30 (14), 3939–3948 (2014).
   PubMed Web of Science ®Google Scholar
• Nakanishi T Fukushima S Okamoto K et al. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release74 (1–3), 295–302 (2001).
   PubMed Web of Science ®Google Scholar
• Matsumura Y Hamaguchi T Ura T et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer91 (10), 1775–1781 (2004).
   PubMed Web of Science ®Google Scholar
• Kato K Chin K Yoshikawa T et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest. New Drugs30 (4), 1621–1627 (2012).
   PubMed Web of Science ®Google Scholar
• Hamaguchi T Kato K Yasui H et al. A Phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation. Br. J. Cancer97 (2), 170–176 (2007).
   PubMed Web of Science ®Google Scholar
• Negishi T Koizumi F Uchino H et al. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared with free paclitaxel. Br. J. Cancer95 (5), 601–606 (2006).
   PubMed Web of Science ®Google Scholar
• Knight SW Bass BL . A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science293 (5538), 2269–2271 (2001).
   PubMed Web of Science ®Google Scholar
• Yanagihara K Takigahira M Kubo T Ochiya T Hamaguchi T Matsumura Y . Marked antitumor effect of NK012, a SN-38-incorporating micelle formulation, in a newly developed mouse model of liver metastasis resulting from gastric cancer. Ther. Deliv.5 (2), 129–138 (2014).
   PubMedGoogle Scholar
• Hamaguchi T Doi T Eguchi-Nakajima T et al. Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors. Clin. Cancer Res.16 (20), 5058–5066 (2010).
   PubMed Web of Science ®Google Scholar
• Baba M Matsumoto Y Kashio A et al. Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs. J. Control. Release157 (1), 112–117 (2012).
   PubMed Web of Science ®Google Scholar
• Plummer R Wilson RH Calvert H et al. A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumors. Br. J. Cancer104 (4), 593–598 (2011).
   PubMed Web of Science ®Google Scholar
• Ueno T Endo K Hori K et al. Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016). Int. J. Nanomedicine9, 3005–3012 (2014).
   PubMed Web of Science ®Google Scholar
• Lee KS Chung HC Im SA et al. Multicenter Phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer. Breast Cancer Res. Treat.108 (2), 241–250 (2008).
   PubMed Web of Science ®Google Scholar
• Lim WT Tan EH Toh CK et al. Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann. Oncol.21 (2), 382–388 (2010).
   PubMed Web of Science ®Google Scholar
• Kim DW Kim SY Kim HK et al. Multicenter Phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol.18 (12), 2009–2014 (2007).
   PubMed Web of Science ®Google Scholar
• Kim TY Kim DW Chung JY et al. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res.10 (11), 3708–3716 (2004).
   PubMed Web of Science ®Google Scholar
• Danson S Ferry D Alakhov V et al. Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br. J. Cancer90 (11), 2085–2091 (2004).
   PubMed Web of Science ®Google Scholar
• Valle JW Armstrong A Newman C et al. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest. New Drugs29 (5), 1029–1037 (2011).
   PubMed Web of Science ®Google Scholar